Standardized End Point Definitions for Clinical Trials in Thoracic Aortic Repair: A Consensus Report From the ARCH–Academic Research Consortium

A Adam W. Beck (Department of Surgery and Division of Vascular Surgery and Endovascular Therapy, University of Alabama at Birmingham (A.W.B.).) N Nimesh D. Desai (Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia (N.D.D.).) D Dorothy Abel (Abel and Wolf Consulting, Santa Rosa, CA (D.A.).) C Cherrie Z. Abraham (Division of Vascular Surgery, Oregon Health & Science University, Portland (C.Z.A.).) J Joseph E. Bavaria (Jefferson Health and the University’s Sidney Kimmel Medical College, Philadelphia, PA (J.E.B.).) J Jeffrey N. Browndyke (Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC (J.N.B.).) R Rachel E. Clough (School of Biomedical Engineering and Imaging Science, King’s College London, St. Thomas’ Hospital, UK (R.E.C.).) J Jean-Philippe Collet D Donald E. Cutlip (Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (D.E.C.).) M Martin Czerny M Matthew J. Eagleton (Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston (M.J.E.).) A Anthony L. Estrera (Department of Cardiothoracic and Vascular Surgery, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, TX (A.L.E.).) D Dominik Fleischmann (Department of Radiology, Stanford University School of Medicine, Palo Alto, CA (D.F.).) S Stephan Haulon (Division of Vascular Surgery, Aortic Centre, Hôspital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris-Saclay, France (S.H.).) R Robin H. Heijmen (Department of Cardio-Thoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands (R.H.H.).) K Karen M. Kim (University of Texas Health Austin/Dell Medical School (K.M.K.).) T Tilo Kölbel (Department of Vascular Medicine, German Aortic Center, University Medical Center Hamburg-Eppendorf, Hamburg (T.K.).) M Mitchell W. Krucoff (Duke University Medical Center/Duke Clinical Research Institute, Durham, NC (M.W.K.).) A Alexandra J. Lansky (Department of Internal Medicine, Section of Cardiology, Yale School of Medicine, New Haven, CT (A.J.L.).) B Bradley G. Leshnower (Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, GA (B.G.L.).) S Sean P. Lyden (Heart Vascular and Thoracic Institute, Department of Vascular Surgery, Cleveland Clinic, OH (S.P.L.).) M Michael Mack (From Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ (P.G.); Columbia University Medical Center/New York Presbyterian Hospital (A.S., R.T.H., M.B.L.), the Cardiovascular Research Foundation (D.J.C., R.T.H., B.R., M.B.L.), and Weill Cornell Medicine (B.R.), New York, and St. Francis Hospital and Heart Center, Roslyn (D.J.C.) — all in New York; University of Colorado Health, Medical Center of the Rockies, Loveland (J.B.O.); Laval University, Quebec, QC (P.P.), St. Paul’s Hospital, University of British Columbia, Vancouver (P.B., J.L.), and McMaster University, Hamilton, ON (T.S.) — all in Canada; Vanderbilt University Medical Center, Nashville (B.R.L., K.G.); Emory University, Atlanta (V.B.); the Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, Stanford (W.F.F.), VA Palo Alto Health Care System, Palo Alto (W.F.F.), California Pacific Medical Center, San Francisco (D.V.D.), Cedars–Sinai Medical Center, Los Angeles (R.R.M.), and Edwards ...) T Tara M. Mastracci (Division of Surgery and Interventional Sciences, University College London, UK (T.M.M.).) J Jon S. Matsumura R Roxana Mehran (Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.M.).) G Germano Melissano (Division of Vascular Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy (G.M.).) S Steven R. Messé (Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia (S.R.M.).) M Marie-Claude Morice (Department of Cardiology, Cardiovascular Institute Paris-Sud, Hopital Privé Jacques Cartier, Ramsay Générale de Santé, Massy, France (M.-C.M.).) C Christoph A. Nienaber G Gustavo S. Oderich (Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, TX (G.S.O.).) K Kenneth Ouriel (NAMSA, Northwood, OH (K.O.).) M Maral Ouzounian O Ourania Preventza (Heart Surgeons of San Antonio, TX (O.P.).) T Timothy A. Resch (Department of Vascular Surgery, Copenhagen Aortic Centre, Copenhagen University Hospital, Rigshospitalet, Denmark (T.A.R.).) E Eric E. Roselli (Aorta Center, Department of Thoracic and Cardiovascular Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic, OH (E.E.R.).) E Ernest Spitzer (Cardialysis, Rotterdam, the Netherlands) G Gregory Piazza (Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School, Boston)

Abstract

Innovation in the treatment of ascending aorta and arch pathology with novel catheter-based and hybrid procedures has driven the need for a strategy to guide their safe application. The ARCH-ARC (Aortic Arch Academic Research Consortium) was established to pragmatically develop consistent clinical end points and to standardize definitions for use in studies of these new technologies. The ARCH-ARC team, consisting of independent international specialists in cardiac surgery, vascular surgery, vascular medicine, cardiology, neurology, radiology, and clinical trials, along with US Food and Drug Administration, industry, and contract research organization representatives, held virtual meetings from 2021 to 2025. Consensus was used to identify appropriate clinical end points and to standardize definitions of end points for endovascular, hybrid, and open surgical procedures in clinical trials in the ascending aorta and arch. Drawing on previous ARC work in cardiac, neurological, renal, and bleeding end points, the ARCH-ARC focused on definitions and end points related to aortic arch–specific anatomy, pathology, and procedures and clinical, device, and imaging. The adoption of the ARCH-ARC consensus definitions and end points will provide a template for consistent adjudication and event reporting and facilitate comparisons of clinical research studies involving devices for ascending aorta and arch pathology.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue 22
Published June 02, 2026
Pages 1761-1780
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (37)

A

Adam W. Beck

Department of Surgery and Division of Vascular Surgery and Endovascular Therapy, University of Alabama at Birmingham (A.W.B.).

N

Nimesh D. Desai

Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia (N.D.D.).

D

Dorothy Abel

Abel and Wolf Consulting, Santa Rosa, CA (D.A.).

C

Cherrie Z. Abraham

Division of Vascular Surgery, Oregon Health & Science University, Portland (C.Z.A.).

J

Joseph E. Bavaria

Jefferson Health and the University’s Sidney Kimmel Medical College, Philadelphia, PA (J.E.B.).

J

Jeffrey N. Browndyke

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC (J.N.B.).

R

Rachel E. Clough

School of Biomedical Engineering and Imaging Science, King’s College London, St. Thomas’ Hospital, UK (R.E.C.).

J

Jean-Philippe Collet

D

Donald E. Cutlip

Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (D.E.C.).

M

Martin Czerny

M

Matthew J. Eagleton

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston (M.J.E.).

A

Anthony L. Estrera

Department of Cardiothoracic and Vascular Surgery, McGovern Medical School, University of Texas Health Science Center at Houston and Memorial Hermann Hospital, TX (A.L.E.).

D

Dominik Fleischmann

Department of Radiology, Stanford University School of Medicine, Palo Alto, CA (D.F.).

S

Stephan Haulon

Division of Vascular Surgery, Aortic Centre, Hôspital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris-Saclay, France (S.H.).

R

Robin H. Heijmen

Department of Cardio-Thoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands (R.H.H.).

K

Karen M. Kim

University of Texas Health Austin/Dell Medical School (K.M.K.).

T

Tilo Kölbel

Department of Vascular Medicine, German Aortic Center, University Medical Center Hamburg-Eppendorf, Hamburg (T.K.).

M

Mitchell W. Krucoff

Duke University Medical Center/Duke Clinical Research Institute, Durham, NC (M.W.K.).

A

Alexandra J. Lansky

Department of Internal Medicine, Section of Cardiology, Yale School of Medicine, New Haven, CT (A.J.L.).

B

Bradley G. Leshnower

Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, GA (B.G.L.).

S

Sean P. Lyden

Heart Vascular and Thoracic Institute, Department of Vascular Surgery, Cleveland Clinic, OH (S.P.L.).

M

Michael Mack

From Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ (P.G.); Columbia University Medical Center/New York Presbyterian Hospital (A.S., R.T.H., M.B.L.), the Cardiovascular Research Foundation (D.J.C., R.T.H., B.R., M.B.L.), and Weill Cornell Medicine (B.R.), New York, and St. Francis Hospital and Heart Center, Roslyn (D.J.C.) — all in New York; University of Colorado Health, Medical Center of the Rockies, Loveland (J.B.O.); Laval University, Quebec, QC (P.P.), St. Paul’s Hospital, University of British Columbia, Vancouver (P.B., J.L.), and McMaster University, Hamilton, ON (T.S.) — all in Canada; Vanderbilt University Medical Center, Nashville (B.R.L., K.G.); Emory University, Atlanta (V.B.); the Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, Stanford (W.F.F.), VA Palo Alto Health Care System, Palo Alto (W.F.F.), California Pacific Medical Center, San Francisco (D.V.D.), Cedars–Sinai Medical Center, Los Angeles (R.R.M.), and Edwards ...

T

Tara M. Mastracci

Division of Surgery and Interventional Sciences, University College London, UK (T.M.M.).

J

Jon S. Matsumura

R

Roxana Mehran

Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.M.).

G

Germano Melissano

Division of Vascular Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy (G.M.).

S

Steven R. Messé

Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia (S.R.M.).

M

Marie-Claude Morice

Department of Cardiology, Cardiovascular Institute Paris-Sud, Hopital Privé Jacques Cartier, Ramsay Générale de Santé, Massy, France (M.-C.M.).

C

Christoph A. Nienaber

G

Gustavo S. Oderich

Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, TX (G.S.O.).

K

Kenneth Ouriel

NAMSA, Northwood, OH (K.O.).

M

Maral Ouzounian

O

Ourania Preventza

Heart Surgeons of San Antonio, TX (O.P.).

T

Timothy A. Resch

Department of Vascular Surgery, Copenhagen Aortic Centre, Copenhagen University Hospital, Rigshospitalet, Denmark (T.A.R.).

E

Eric E. Roselli

Aorta Center, Department of Thoracic and Cardiovascular Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic, OH (E.E.R.).

E

Ernest Spitzer

Cardialysis, Rotterdam, the Netherlands

G

Gregory Piazza

Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School, Boston